Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eigen has reported that its new imaging device, Artemis, has received clearance from the FDA. Artemis is said to offer urologists breakthrough technology that will significantly help in the fight against prostate cancer.
Subscribe to our email newsletter
According to the company, Artemis’s 3D/4D imaging allows doctors to select and biopsy a location within the boundary of the prostate with pinpoint accuracy. The biopsy location is then recorded by Artemis’s patented registration technology, which allows doctors to revisit or avoid the exact same area during repeat procedures. Artemis provides doctors with data they can analyze to determine if the prostate gland has changed and manage treatment accordingly.
The first Artemis imaging systems will be in use at the University of Colorado Health Sciences Center and UC San Francisco within weeks and are available for immediate order in the US.
Michael Castorino, CEO of Eigen, said: “Artemis is intended to give the nation’s nearly 10,000 urologists the technology to navigate to a desired location for prostate biopsy and record this information for future reference, treatment planning and monitoring.”